Generic placeholder image

Cardiovascular & Hematological Agents in Medicinal Chemistry


ISSN (Print): 1871-5257
ISSN (Online): 1875-6182

Research Article

Radioprotective Effect of Pioglitazone Against Genotoxicity Induced by Ionizing Radiation in Healthy Human Lymphocytes

Author(s): Roya Kazemi and Seyed J. Hosseinimehr*

Volume 19, Issue 1, 2021

Published on: 24 May, 2020

Page: [72 - 75] Pages: 4

DOI: 10.2174/1871525718666200525005231

Price: $65


Objective: Pioglitazone (PG) is used to control high blood sugar in patients with type 2 diabetes mellitus. PG acts as a peroxisome proliferator-activated receptor γ agonist. In addition to the insulin-sensitizing effect, PG possesses anti-inflammatory effect. In this study, the protective effect of PG was evaluated against DNA damage induced by ionizing radiation in healthy human lymphocytes.

Methods: The microtubes containing human whole blood were treated with PG at various concentrations (1-50 μM) for three hours. Then, the blood samples were irradiated with X-ray. Lymphocytes were cultured for determining the frequency of micronuclei as a genotoxicity biomarker in binucleated lymphocytes.

Results: The mean percentage of micronuclei was significantly increased in human lymphocytes when exposed to IR, while it was decreased in lymphocytes pre-treated with PG. The maximum reduction in the frequency of micronuclei in irradiated lymphocytes was observed at 5 μM of PG treatment (48% decrease).

Conclusion: The anti-inflammatory property suggested the mechanism action of PG for protecting human lymphocytes against genotoxicity induced by ionizing radiation.

Keywords: Anti-inflammatory, DNA damage, micronucleus test, pioglitazone, radiation biology, radioprotective.

Graphical Abstract
Hosseinimehr, S.J. Trends in the development of radioprotective agents. Drug Discov. Today, 2007, 12(19-20), 794-805.
[] [PMID: 17933679]
Salehifar, E.; Hosseinimehr, S.J. The use of cyclooxygenase-2 inhibitors for improvement of efficacy of radiotherapy in cancers. Drug Discov. Today, 2016, 21(4), 654-662.
[] [PMID: 26955911]
Devchand, P.R.; Liu, T.; Altman, R.B.; FitzGerald, G.A.; Schadt, E.E. The pioglitazone trek via human PPAR gamma: From discovery to a medicine at the FDA and beyond. Front. Pharmacol., 2018, 9, 1093.
[] [PMID: 30337873]
Marion-Letellier, R.; Savoye, G.; Ghosh, S. Fatty acids, eicosanoids and PPAR gamma. Eur. J. Pharmacol., 2016, 785, 44-49.
[] [PMID: 26632493]
Janani, C.; Ranjitha Kumari, B.D. PPAR gamma gene--a review. Diabetes Metab. Syndr., 2015, 9(1), 46-50.
[] [PMID: 25450819]
Cippitelli, A.; Domi, E.; Ubaldi, M.; Douglas, J.C.; Li, H.W.; Demopulos, G.; Gaitanaris, G.; Roberto, M.; Drew, P.D.; Kane, C.J.M.; Ciccocioppo, R. Protection against alcohol-induced neuronal and cognitive damage by the PPARγ receptor agonist pioglitazone. Brain Behav. Immun., 2017, 64, 320-329.
[] [PMID: 28167117]
Hong, S.W.; Lee, J.; Cho, J.H.; Kwon, H.; Park, S.E.; Rhee, E.J.; Park, C.Y.; Oh, K.W.; Park, S.W.; Lee, W.Y. pioglitazone attenuates palmitate-induced inflammation and endoplasmic reticulum stress in pancreatic β-cells. Endocrinol. Metab., 2018, 33(1), 105-113.
[] [PMID: 29589392]
Gao, M.; Jiang, Y.; Xiao, X.; Peng, Y.; Xiao, X.; Yang, M. Protective effect of pioglitazone on sepsis-induced intestinal injury in a rodent model. J. Surg. Res., 2015, 195(2), 550-558.
[] [PMID: 25772146]
Kandeel, S.; Balaha, M. The possible protective effect of simvastatin and pioglitazone separately and in combination on bleomycin-induced changes in mice thin skin. Tissue Cell, 2015, 47(2), 159-170.
[] [PMID: 25712322]
Charkhpour, M.; Ghavimi, H.; Ghanbarzadeh, S.; Yousefi, B.; Khorrami, A.; Mesgari, M.; Hassanzadeh, K. Protective effect of pioglitazone on morphine-induced neuroinflammation in the rat lumbar spinal cord. J. Biomed. Sci., 2015, 22, 82.
[] [PMID: 26394827]
Refaie, M.M.M.; El-Hussieny, M. Protective effect of pioglitazone on ovarian ischemia reperfusion injury of female rats via modulation of peroxisome proliferator activated receptor gamma and heme-oxygenase 1. Int. Immunopharmacol., 2018, 62, 7-14.
[] [PMID: 29966944]
Wittayalertpanya, S.; Chompootaweep, S.; Thaworn, N. The pharmacokinetics of pioglitazone in Thai healthy subjects. J. Med. Assoc. Thai., 2006, 89(12), 2116-2122.
[PMID: 17214065]
Hosseinimehr, S.J.; Fathi, M.; Ghasemi, A.; Shiadeh, S.N.; Pourfallah, T.A. Celecoxib mitigates genotoxicity induced by ionizing radiation in human blood lymphocytes. Res. Pharm. Sci., 2017, 12(1), 82-87.
[] [PMID: 28255318]
Hosseinimehr, S.J.; Nobakht, R.; Ghasemi, A.; Pourfallah, T.A. Radioprotective effect of mefenamic acid against radiation-induced genotoxicity in human lymphocytes. Radiat. Oncol. J., 2015, 33(3), 256-260.
[] [PMID: 26484310]
Asemi, S.; Ghaemi, A.; Hosseinimehr, S.J. Febuxostat mitigates genotoxicity induced by ionizing radiation in human normal lymphocytes. Erciyes Med. J., 2019, 41(1), 99-101.
Rojo de la Vega, M.; Krajisnik, A.; Zhang, D.D.; Wondrak, G.T. Targeting NRF2 for improved skin barrier function and photoprotection: Focus on the achiote-derived apocarotenoid bixin. Nutrients, 2017, 9(12)E1371
[] [PMID: 29258247]
Li, Y.; Xia, T.; Li, R.; Tse, G.; Liu, T.; Li, G. Renal-protective effects of the peroxisome proliferator-activated receptor-γ agonist pioglitazone in ob/ob Mice. Med. Sci. Monit., 2019, 25, 1582-1589.
[] [PMID: 30820023]
Meng, X.; Sun, X.; Zhang, Y.; Shi, H.; Deng, W.; Liu, Y.; Wang, G.; Fang, P.; Yang, S. PPARγ agonist PGZ attenuates OVA-induced airway inflammation and airway remodeling via RGS4 signaling in mouse model. Inflammation, 2018, 41(6), 2079-2089.
[] [PMID: 30022363]
Zhang, H.B.; Zhang, Y.; Chen, C.; Li, Y.Q.; Ma, C.; Wang, Z.J. Pioglitazone inhibits advanced glycation end product-induced matrix metalloproteinases and apoptosis by suppressing the activation of MAPK and NF-κB. Apoptosis, 2016, 21(10), 1082-1093.
[] [PMID: 27515513]
Pordanjani, S.M.; Hosseinimehr, S.J. The role of NF-kB inhibitors in cell response to radiation. Curr. Med. Chem., 2016, 23(34), 3951-3963.
[ ] [PMID: 27554808]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy